Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients

Table 3

Multivariable Cox regression models for overall graft loss in recipients with HCV negative liver disease.

	Pre-/intra-operative model			Early post-operative model
	HR	(95% CI)	P	HR	(95% CI)	P
Donor anti-HBc serum status; (positive versus negative)	3.303	1.601-6.814	0.001	2.855	1.329-6.134	0.007
Sd-MaS categorical, n (%): 0% (reference)
1-15%	1.223	0.587-2.547	0.591	1.357	0.641-2.871	0.425
>15%	2.891	1.312-6.369	0.008	2.623	1.169-5.888	0.019
IPGF (yes vs no)				1.094	0.494-2.426	0.824
EAD (yes vs no)				1.849	0.891-3.838	0.099
Transplant year	0.947	0.851-1.053	0.315	0.969	0.863-1.087	0.589

Sd-MaS, small droplet macrovesicular steatosis; IPGF, initial poor graft function; EAD, early allograft dysfunction.